Dr. Tuluc is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
132 S 10th St
# 285K
Philadelphia, PA 19107Phone+1 215-503-5642Fax+1 215-503-4817
Education & Training
- University of Medicine and Pharmacy ‘Gr T Popa” Iasi Class of 1992
Certifications & Licensure
- NJ State Medical License 2018 - 2025
- PA State Medical License 2002 - 2024
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 52 citationsDesmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytesAndrew M. Overmiller, Jennifer A. Pierluissi, Peter J. Wermuth, Sami Sauma, Ubaldo E. Martinez-Outschoorn
FASEB Journal. 2017-04-24 - 4 citationsNivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck.Jennifer M Johnson, Ioannis A Vathiotis, Larry A Harshyne, Ayesha Ali, Voichita Bar Ad
Journal for Immunotherapy of Cancer. 2023-08-01 - 93 citationsSalivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression.Lindsay Williams, Lester D.R. Thompson, Raja R. Seethala, Ilan Weinreb, Adel Assaad
The American Journal of Surgical Pathology. 2015-05-01
Press Mentions
- Diabetes Drug Takes Aim at Cancer's Fuel SourceJanuary 25th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: